CN105287626A - Mucosa injection - Google Patents
Mucosa injection Download PDFInfo
- Publication number
- CN105287626A CN105287626A CN201510700604.1A CN201510700604A CN105287626A CN 105287626 A CN105287626 A CN 105287626A CN 201510700604 A CN201510700604 A CN 201510700604A CN 105287626 A CN105287626 A CN 105287626A
- Authority
- CN
- China
- Prior art keywords
- mucosa injection
- mucosa
- injection agent
- methylene blue
- sodium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a mucosa injection. The mucosa injection is prepared by mixing odium hyaluronate and brine containing sodium chloride and adding a small amount of methylene blue for color development. The mucosa injection has the advantages of being simple in medicine preparing method, low in preparing cost, good in effect and capable of being prepared when needed.
Description
Technical field
The invention belongs to technical field of pharmaceuticals, relate to a kind of mucosa injection agent.
Background technology
Therapeutic endoscopy operation in for submucosal injections, for patient provides surgical field of view clearly, and at utmost avoid perforation and hemorrhage.In existing mucosa injection, mucosa injection agent Pharmaceutical setting method is complicated, and deployment cost is high, can not matching while using.
Summary of the invention
The object of the present invention is to provide a kind of mucosa injection agent, solve existing mucosa injection agent Pharmaceutical setting method complicated, deployment cost is high, can not matching while using.
The technical solution adopted in the present invention adopts hyaluronic acid sodium and the saline containing sodium chloride to mix, and adds the colour developing of a small amount of methylene blue and make.
Further, described hyaluronic acid sodium 20mg, the saline 8ml containing 0.9% sodium chloride, methylene blue 0.5mg are mixed with and form.
The invention has the beneficial effects as follows that the mucosa injection agent Pharmaceutical setting method of use is simple, deployment cost is low effective, can matching while using.
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention is described in detail.
Mucosa injection agent of the present invention, adopts hyaluronic acid sodium and the saline containing sodium chloride to mix, and adds the colour developing of a small amount of methylene blue and makes.
Optimum ratio: hyaluronic acid sodium 20mg, the saline 8ml containing 0.9% sodium chloride, methylene blue 0.5mg.
The present invention is applicable to esophagus early cancer decollement under scope: these product of submucosal injections, diseased region can be made to praise well, and mucosa injection agent of the present invention, can extend the time of praising, and provides surgical field of view clearly.Be conducive to patient and divest pathological changes smoothly, shorten operating time and anesthesia duration, and effectively avoid perforation and hemorrhage.Can at various Endoscopic Treatment, as ESD, EMR, POEM etc.
The above is only to better embodiment of the present invention, not any pro forma restriction is done to the present invention, every any simple modification done above embodiment according to technical spirit of the present invention, equivalent variations and modification, all belong in the scope of technical solution of the present invention.
Claims (2)
1. a mucosa injection agent, is characterized in that: adopt hyaluronic acid sodium and the saline containing sodium chloride to mix, and adds the colour developing of a small amount of methylene blue and makes.
2. according to mucosa injection agent a kind of described in claim 1, it is characterized in that: described hyaluronic acid sodium 20mg, the saline 8ml containing 0.9% sodium chloride, methylene blue 0.5mg are mixed with and form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510700604.1A CN105287626A (en) | 2015-10-26 | 2015-10-26 | Mucosa injection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510700604.1A CN105287626A (en) | 2015-10-26 | 2015-10-26 | Mucosa injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105287626A true CN105287626A (en) | 2016-02-03 |
Family
ID=55185914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510700604.1A Pending CN105287626A (en) | 2015-10-26 | 2015-10-26 | Mucosa injection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105287626A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106267379A (en) * | 2016-06-02 | 2017-01-04 | 山东威高药业股份有限公司 | Hetastarch application in interior arthroscopic diagnosis |
| CN107456612A (en) * | 2016-06-02 | 2017-12-12 | 山东威高药业股份有限公司 | Submucosal injection solution |
| WO2018134621A1 (en) * | 2017-01-19 | 2018-07-26 | Diagmed Healthcare Limited | Polyp lifting compositions and methods for use |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488911A (en) * | 2011-11-29 | 2012-06-13 | 上海景峰制药有限公司 | Sodium hyaluronate injection sterilization method for guaranteeing aseptic packaging |
-
2015
- 2015-10-26 CN CN201510700604.1A patent/CN105287626A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488911A (en) * | 2011-11-29 | 2012-06-13 | 上海景峰制药有限公司 | Sodium hyaluronate injection sterilization method for guaranteeing aseptic packaging |
Non-Patent Citations (3)
| Title |
|---|
| 李红平等: "内镜黏膜下剥离术治疗近环周早期食管癌及癌前病变的价值", 《第三军医大学学报》 * |
| 陈更等: "黏膜下注射玻璃酸钠在内镜黏膜下剥离术中的应用研究", 《中国实用内科杂志》 * |
| 高飞等: "玻璃酸钠、去甲肾上腺素、靛胭脂混合溶液在内镜黏膜下剥离术中的临床应用", 《解放军医学杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106267379A (en) * | 2016-06-02 | 2017-01-04 | 山东威高药业股份有限公司 | Hetastarch application in interior arthroscopic diagnosis |
| CN107456612A (en) * | 2016-06-02 | 2017-12-12 | 山东威高药业股份有限公司 | Submucosal injection solution |
| WO2018134621A1 (en) * | 2017-01-19 | 2018-07-26 | Diagmed Healthcare Limited | Polyp lifting compositions and methods for use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104187004B (en) | The Chinese herbal feed additive of a kind of prevention and supplemental treatment shrimp crab crust canker | |
| CN105287626A (en) | Mucosa injection | |
| CN104069120B (en) | Thixotropy hydrogel of the two medicines of a kind of load for local treatment of tumor and preparation method thereof | |
| CN104107174A (en) | Health hollow capsule | |
| RU2004114282A (en) | METHOD AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING THE ACTIVITY OF CANCER CELLS | |
| CN110279593A (en) | A kind of compounding nutrient solution for comprehensive solution eye circumference aging | |
| CN103623003B (en) | A kind of ZHENZHU MINGMU DIYANYE and preparation method thereof | |
| Huang et al. | Ethyl pyruvate inhibits glioblastoma cells migration and invasion through modulation of NF-κB and ERK-mediated EMT | |
| MX2019008482A (en) | Medical treatment comprising enteral administration of edaravone. | |
| CN103169652B (en) | Veterinary alkaline lincomycin injection as well as preparation method and use thereof | |
| Sanches Junior et al. | Adverse mucocutaneous reactions to chemotherapeutic agents: part I | |
| CN101978945B (en) | A kind of ibuprofen medicinal composition | |
| RU2458639C1 (en) | Method of preventing complication in surgical treatment of thyroid gland diseases | |
| RU2015145451A (en) | PRODUCTS FOR LOCAL USE CONTAINING HYALURONIC ACID, VERBASCOZIDE AND GLYCEROPHOSPHOINOSITOL | |
| CN106474097B (en) | Anticancer agent | |
| CN103860474A (en) | Doxycycline soluble powder production method | |
| CN103565736A (en) | Hydroxyethyl starch 130 sodium acetate Ringer injection and preparation method thereof | |
| CA2780119A1 (en) | Capsule for oral pet medicine | |
| CN102266298A (en) | Pharmaceutical composition of pemetrexed disodium | |
| CN104257683A (en) | Application of lauromacrogol in preparing medicament for treating sublingual gland cyst | |
| CN104337797A (en) | Preparation method of multi-medicine-integrated drug-loading composite fiber membrane | |
| CN105412126B (en) | Composition containing SASP and its application in treatment ulcerative colitis medicine is prepared | |
| CN103041227A (en) | Liver benefiting powder | |
| CN104857074A (en) | Formula of traditional Chinese medicine for treating acne | |
| CN103768085B (en) | A kind of veterinary medical composition treating respiratory tract infection and its production and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160203 |
|
| RJ01 | Rejection of invention patent application after publication |